Clinical course of patients with non–small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib
Purpose: In patients with non–small cell lung cancer (NSCLC), mutations in the epidermal
growth factor receptor (EGFR) tyrosine kinase domain have been associated with sensitivity …
growth factor receptor (EGFR) tyrosine kinase domain have been associated with sensitivity …
Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or …
GJ Riely, W Pao, DK Pham, AR Li, N Rizvi… - Clinical Cancer …, 2006 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: In patients with non–small cell lung
cancer (NSCLC), mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase …
cancer (NSCLC), mutations in the epidermal growth factor receptor (EGFR) tyrosine kinase …
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib
GJ Riely, W Pao, D Pham, AR Li… - … : an official journal …, 2006 - pubmed.ncbi.nlm.nih.gov
Purpose In patients with non-small cell lung cancer (NSCLC), mutations in the epidermal
growth factor receptor (EGFR) tyrosine kinase domain have been associated with sensitivity …
growth factor receptor (EGFR) tyrosine kinase domain have been associated with sensitivity …
[引用][C] Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon19 and exon 21 mutations treated with gefitinib or erlotinib
GJ RIELY, W PAO, D PHAM, AR LI… - Clinical cancer …, 2006 - pascal-francis.inist.fr
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor
exon19 and exon 21 mutations treated with gefitinib or erlotinib CNRS Inist Pascal-Francis …
exon19 and exon 21 mutations treated with gefitinib or erlotinib CNRS Inist Pascal-Francis …
[引用][C] Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib
R GJ - Clin Cancer Res, 2006 - cir.nii.ac.jp
Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor
exon 19 and exon 21 mutations treated with gefitinib or erlotinib | CiNii Research CiNii 国立 …
exon 19 and exon 21 mutations treated with gefitinib or erlotinib | CiNii Research CiNii 国立 …